Nifty

:

18726.40

Sensex

:

63142.96

127.40 (0.69%)
350.08 (0.56%)

Login

Nifty
Sensex

:
:

18726.40
63142.96

127.40 (0.69%)
350.08 (0.56%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :

47/99

BSE: 532305 | NSE: INDSWFTLAB

Watchlist

NSE BSE

71.00

07-Jun-2023

Day's Open
Day's High
Day's Low
Previous Close

72.10
72.60
70.90
71.90

Volume
Traded Value (lacs)
52 Week High
52 Week Low

55946
40.08
80.00
52.65

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

424.42
8.92
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

1,355.45
N/A
0.85

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-0.89
6.38
10.04

EBITDA CAGR (%)

10 Years
5 Years
3 Years

10.59
7.85
6.40

PAT CAGR (%)

10 Years
5 Years
3 Years

-33.00
-
-53.36

P:E (Median)

8 Years
5 Years
3 Years

-
7.44
11.99

P:BV (Average)

8 Years
5 Years
3 Years

0.79
0.83
0.90

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.46
7.23
6.48

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 290.48 275.82 5.32% 302.41 240.30 25.85% 287.55 229.92 25.07% 271.52 242.05 12.18%
Expenses 234.14 240.74 -2.74% 246.49 186.73 32.00% 230.69 175.35 31.56% 218.54 191.41 14.17%
EBITDA 56.34 35.08 60.60% 55.91 53.57 4.37% 56.85 54.57 4.18% 52.99 50.64 4.64%
EBIDTM 19.40% 12.72% 18.49% 22.29% 19.77% 23.74% 19.51% 20.92%
Other Income 9.99 20.63 -51.58% 8.36 7.99 4.63% 7.54 7.35 2.59% 7.39 6.37 16.01%
Interest 21.82 23.49 -7.11% 22.38 23.73 -5.69% 23.98 24.20 -0.91% 23.98 24.12 -0.58%
Depreciation 9.29 81.78 -88.64% 15.43 21.26 -27.42% 16.39 13.87 18.17% 16.26 14.06 15.65%
PBT 8.57 -49.56 - 26.46 14.87 77.94% 24.02 23.85 0.71% 20.14 18.83 6.96%
Tax 39.48 13.63 189.66% -2.76 0.00 - 0.00 0.00 0 0.00 0.08 -100.00%
PAT -30.91 -63.19 - 29.22 14.87 96.50% 24.02 23.85 0.71% 20.14 18.75 7.41%
PATM -10.64% -22.91% 9.66% 6.19% 8.35% 10.37% 7.42% 7.75%
EPS -5.23 -10.69 - 4.94 2.52 96.03% 4.06 4.04 0.50% 3.41 3.17 7.57%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 304.25 306.65 -0.78% 312.69 246.64 26.78% 310.21 235.64 31.65% 280.17 249.80 12.16%
Expenses 239.53 269.95 -11.27% 258.92 194.25 33.29% 251.46 179.59 40.02% 227.16 198.97 14.17%
EBITDA 64.71 36.69 76.37% 53.76 52.39 2.62% 58.75 56.06 4.80% 53.00 50.83 4.27%
EBIDTM 21.27% 11.97% 17.19% 21.24% 18.94% 23.79% 18.92% 20.35%
Other Income 10.21 21.21 -51.86% 8.36 8.41 -0.59% 7.54 7.15 5.45% 7.39 6.37 16.01%
Interest 21.82 23.49 -7.11% 22.38 23.73 -5.69% 23.98 24.19 -0.87% 23.98 24.12 -0.58%
Depreciation 9.29 81.81 -88.64% 15.39 21.26 -27.61% 16.41 13.91 17.97% 16.28 14.06 15.79%
PBT 17.16 -47.40 - 24.35 15.81 54.02% 25.91 25.10 3.23% 20.14 19.02 5.89%
Tax 41.17 14.06 192.82% -3.27 -0.22 - 0.56 0.63 -11.11% 0.22 0.21 4.76%
PAT -24.01 -61.45 - 27.62 16.03 72.30% 25.34 24.47 3.56% 19.92 18.80 5.96%
PATM -7.89% -20.04% 8.83% 6.50% 8.17% 10.38% 7.11% 7.53%
EPS -4.08 -10.40 - 4.65 2.71 71.59% 4.29 4.14 3.62% 3.36 3.18 5.66%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,151.96 988.09 856.58 751.84 724.43 728.33 674.90 638.74 645.74 940.66 1,082.70 Net Sales Growth 16.58% 15.35% 13.93% 3.78% -0.54% 7.92% 5.66% -1.08% -31.35% -13.12% Cost Of Goods Sold 616.85 487.31 424.99 378.85 379.33 372.09 377.00 344.31 398.54 737.30 865.14 Gross Profit 535.11 500.77 431.58 372.99 345.10 356.23 297.91 294.44 247.19 203.36 217.56 GP Margin 46.45% 50.68% 50.38% 49.61% 47.64% 48.91% 44.14% 46.10% 38.28% 21.62% 20.09% Total Expenditure 929.86 794.38 676.10 610.78 599.15 601.53 569.87 532.05 556.91 882.26 1,012.36 Power & Fuel Cost - 57.48 37.31 34.65 37.44 29.58 26.00 22.65 34.78 36.82 31.61 % Of Sales - 5.82% 4.36% 4.61% 5.17% 4.06% 3.85% 3.55% 5.39% 3.91% 2.92% Employee Cost - 102.18 95.47 93.58 88.94 85.22 67.53 60.74 48.20 42.59 38.75 % Of Sales - 10.34% 11.15% 12.45% 12.28% 11.70% 10.01% 9.51% 7.46% 4.53% 3.58% Manufacturing Exp. - 65.32 64.24 59.30 50.06 63.50 43.40 38.56 30.13 26.18 28.99 % Of Sales - 6.61% 7.50% 7.89% 6.91% 8.72% 6.43% 6.04% 4.67% 2.78% 2.68% General & Admin Exp. - 30.38 23.56 23.77 22.89 24.07 19.96 19.33 17.85 19.45 18.23 % Of Sales - 3.07% 2.75% 3.16% 3.16% 3.30% 2.96% 3.03% 2.76% 2.07% 1.68% Selling & Distn. Exp. - 37.78 28.74 20.24 20.41 27.00 28.12 27.89 27.31 13.09 23.47 % Of Sales - 3.82% 3.36% 2.69% 2.82% 3.71% 4.17% 4.37% 4.23% 1.39% 2.17% Miscellaneous Exp. - 13.93 1.77 0.40 0.07 0.06 7.86 18.57 0.09 6.82 23.47 % Of Sales - 1.41% 0.21% 0.05% 0.01% 0.01% 1.16% 2.91% 0.01% 0.73% 0.57% EBITDA 222.09 193.71 180.48 141.06 125.28 126.80 105.03 106.69 88.83 58.40 70.34 EBITDA Margin 19.28% 19.60% 21.07% 18.76% 17.29% 17.41% 15.56% 16.70% 13.76% 6.21% 6.50% Other Income 33.28 41.72 23.13 36.08 47.00 25.70 22.62 15.91 22.25 13.49 17.85 Interest 92.16 94.76 100.20 106.65 92.24 35.36 90.25 106.41 117.29 116.62 139.61 Depreciation 57.37 130.97 87.29 90.06 104.05 86.62 88.26 84.75 84.29 65.77 54.35 PBT 79.19 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 -90.49 -110.49 -105.77 Tax 36.72 13.70 20.52 1.23 20.35 10.96 -16.46 -24.28 -24.12 -20.46 -0.94 Tax Rate 46.37% 171.25% 127.30% -6.29% 34.53% 38.35% 29.29% 29.21% 16.83% 14.29% 0.78% PAT 42.47 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 -119.16 -122.74 -118.97 PAT before Minority Interest 42.47 -5.71 -4.40 -20.79 38.58 17.62 -39.73 -58.86 -119.16 -122.74 -118.97 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 3.69% -0.58% -0.51% -2.77% 5.33% 2.42% -5.89% -9.22% -18.45% -13.05% -10.99% PAT Growth 842.48% - - - 118.96% - - - - - EPS 7.19 -0.97 -0.74 -3.52 6.53 2.98 -6.72 -9.96 -20.16 -20.77 -20.13

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 1,207.32 1,038.73 891.34 779.64 756.60 762.52 697.42 653.25 660.45 965.08 1,136.09 Net Sales Growth 16.23% 16.54% 14.33% 3.05% -0.78% 9.33% 6.76% -1.09% -31.57% -15.05% Cost Of Goods Sold 654.56 526.58 451.44 396.66 403.36 390.56 392.19 353.01 407.39 754.92 911.94 Gross Profit 552.76 512.15 439.90 382.98 353.24 371.96 305.24 300.23 253.07 210.16 224.15 GP Margin 45.78% 49.31% 49.35% 49.12% 46.69% 48.78% 43.77% 45.96% 38.32% 21.78% 19.73% Total Expenditure 977.07 843.11 708.54 636.16 630.48 628.43 591.47 545.97 571.69 906.18 1,064.59 Power & Fuel Cost - 57.54 37.31 34.65 37.44 29.58 26.00 22.65 34.78 36.82 31.61 % Of Sales - 5.54% 4.19% 4.44% 4.95% 3.88% 3.73% 3.47% 5.27% 3.82% 2.78% Employee Cost - 104.66 97.86 95.92 90.98 88.12 69.65 62.76 50.65 44.95 40.57 % Of Sales - 10.08% 10.98% 12.30% 12.02% 11.56% 9.99% 9.61% 7.67% 4.66% 3.57% Manufacturing Exp. - 63.58 64.24 59.30 50.06 63.50 43.40 38.56 30.13 26.35 29.14 % Of Sales - 6.12% 7.21% 7.61% 6.62% 8.33% 6.22% 5.90% 4.56% 2.73% 2.56% General & Admin Exp. - 36.22 27.17 27.58 27.27 28.69 23.33 21.54 20.33 22.37 21.05 % Of Sales - 3.49% 3.05% 3.54% 3.60% 3.76% 3.35% 3.30% 3.08% 2.32% 1.85% Selling & Distn. Exp. - 38.86 28.74 21.65 21.30 27.92 29.06 28.87 28.33 13.95 24.12 % Of Sales - 3.74% 3.22% 2.78% 2.82% 3.66% 4.17% 4.42% 4.29% 1.45% 2.12% Miscellaneous Exp. - 15.67 1.77 0.40 0.07 0.06 7.86 18.57 0.09 6.82 24.12 % Of Sales - 1.51% 0.20% 0.05% 0.01% 0.01% 1.13% 2.84% 0.01% 0.71% 0.54% EBITDA 230.22 195.62 182.80 143.48 126.12 134.09 105.95 107.28 88.76 58.90 71.50 EBITDA Margin 19.07% 18.83% 20.51% 18.40% 16.67% 17.59% 15.19% 16.42% 13.44% 6.10% 6.29% Other Income 33.50 43.48 22.71 33.46 36.91 25.82 22.62 15.91 22.25 14.17 17.87 Interest 92.16 95.53 100.22 106.65 92.24 35.38 90.27 106.42 117.29 116.66 139.72 Depreciation 57.37 131.04 87.29 90.06 104.05 86.62 88.26 84.75 84.29 65.77 54.35 PBT 87.56 12.53 18.01 -19.77 -33.26 37.92 -49.96 -67.98 -90.56 -109.35 -104.71 Tax 38.68 14.68 21.16 1.42 20.73 14.01 -16.17 -24.09 -23.98 -20.05 -0.94 Tax Rate 44.18% 117.16% 117.49% -7.18% 41.73% 38.94% 29.24% 29.10% 16.73% 14.11% 0.79% PAT 48.87 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 -119.37 -122.01 -117.90 PAT before Minority Interest 48.87 -2.15 -3.15 -21.19 28.95 21.98 -39.13 -58.69 -119.37 -122.01 -117.90 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 4.05% -0.21% -0.35% -2.72% 3.83% 2.88% -5.61% -8.98% -18.07% -12.64% -10.38% PAT Growth 2,373.02% - - - 31.71% - - - - - EPS 8.27 -0.36 -0.53 -3.59 4.90 3.72 -6.62 -9.93 -20.20 -20.64 -19.95

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 632.56 638.69 644.61 590.29 543.37 525.88 514.69 592.35 722.86 851.81 Share Capital 59.81 59.81 59.81 48.29 46.00 45.46 41.68 41.68 40.96 39.27 Total Reserves 572.75 578.89 584.80 542.00 495.82 477.95 473.01 550.67 672.57 803.21 Non-Current Liabilities 806.37 832.95 828.33 901.32 437.80 494.76 717.24 811.33 983.36 857.58 Secured Loans 839.07 875.41 885.96 953.86 503.97 563.69 666.84 723.03 862.23 756.52 Unsecured Loans 0.00 0.00 4.93 11.72 16.52 28.32 79.48 93.11 102.17 61.64 Long Term Provisions 17.03 15.73 14.76 14.34 13.32 9.16 0.00 0.00 0.00 0.00 Current Liabilities 313.61 286.71 309.29 342.34 919.84 994.23 949.20 829.78 623.76 654.80 Trade Payables 163.32 123.96 127.12 115.70 116.58 94.95 129.45 129.74 206.34 193.29 Other Current Liabilities 81.47 89.49 99.23 134.13 491.94 493.59 316.09 249.99 23.04 26.89 Short Term Borrowings 63.86 72.58 82.94 92.52 311.31 405.70 503.66 450.05 390.97 421.97 Short Term Provisions 4.96 0.69 0.00 0.00 0.00 0.00 0.00 0.00 3.41 12.66 Total Liabilities 1,752.54 1,758.35 1,782.23 1,833.95 1,901.01 2,014.87 2,181.13 2,233.46 2,329.98 2,364.19 Net Block 626.79 737.64 842.93 900.99 924.38 1,032.35 1,098.52 1,116.60 1,172.53 1,169.39 Gross Block 1,315.21 1,298.09 1,355.90 1,378.74 1,349.06 1,406.63 1,420.29 1,404.00 1,404.04 1,350.08 Accumulated Depreciation 688.42 560.45 512.97 477.75 424.68 374.28 321.78 287.40 231.51 180.68 Non Current Assets 753.32 892.55 937.66 1,016.66 1,095.57 1,210.47 1,272.28 1,327.74 1,358.58 1,359.63 Capital Work in Progress 10.31 18.84 11.45 19.87 68.60 70.26 78.47 112.83 78.10 161.30 Non Current Investment 110.68 55.33 26.36 38.88 39.12 39.35 26.38 26.33 27.21 27.17 Long Term Loans & Adv. 2.84 65.97 56.92 56.92 63.48 54.21 68.92 71.97 80.74 1.76 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 14.31 0.00 0.00 0.00 0.00 Current Assets 999.21 865.80 844.56 817.29 805.44 804.41 908.85 905.72 971.39 1,004.57 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 Inventories 414.00 354.41 342.82 316.61 316.91 343.56 356.02 348.31 377.03 451.44 Sundry Debtors 428.35 400.15 384.66 333.47 382.82 340.82 358.82 374.90 427.27 393.87 Cash & Bank 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75 Other Current Assets 147.48 58.63 38.73 41.82 99.27 105.81 172.58 164.03 148.17 141.40 Short Term Loans & Adv. 92.22 42.66 69.51 96.30 86.22 89.49 159.33 145.42 127.09 114.21 Net Current Assets 685.60 579.09 535.27 474.95 -114.40 -189.83 -40.35 75.94 347.63 349.77 Total Assets 1,752.53 1,758.35 1,782.22 1,833.95 1,901.01 2,014.88 2,181.13 2,233.46 2,329.97 2,364.20

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 600.97 603.51 640.64 587.81 553.24 531.32 517.43 594.85 725.23 853.44 Share Capital 59.81 59.81 59.81 48.29 46.00 45.46 41.68 41.68 40.96 39.27 Total Reserves 541.17 543.70 580.83 539.53 505.69 483.39 475.74 553.17 674.95 804.85 Non-Current Liabilities 813.57 840.15 828.33 901.32 437.80 494.76 717.24 811.33 983.36 859.34 Secured Loans 847.78 884.13 885.96 953.86 503.97 563.69 666.84 723.03 862.23 756.52 Unsecured Loans 0.00 0.00 4.93 11.72 16.52 28.32 79.48 93.11 102.17 63.40 Long Term Provisions 17.03 15.73 14.76 14.34 13.32 9.16 0.00 0.00 0.00 0.00 Current Liabilities 334.50 314.52 323.07 356.00 935.93 1,005.02 950.81 832.82 630.01 663.04 Trade Payables 175.95 138.82 135.23 126.68 128.64 102.36 132.43 134.11 213.71 203.42 Other Current Liabilities 79.13 81.29 72.92 136.49 490.25 496.93 314.60 248.67 21.50 24.98 Short Term Borrowings 74.03 93.43 114.93 92.52 311.31 405.70 503.66 450.05 390.97 421.97 Short Term Provisions 5.39 0.98 0.00 0.31 5.73 0.03 0.12 0.00 3.83 12.67 Total Liabilities 1,748.93 1,758.09 1,792.04 1,845.13 1,926.97 2,031.10 2,185.48 2,239.00 2,338.60 2,375.82 Net Block 627.56 738.65 843.14 901.20 924.59 1,032.56 1,098.73 1,116.82 1,173.77 1,170.63 Gross Block 1,318.99 1,302.04 1,359.32 1,378.95 1,349.27 1,406.84 1,420.51 1,404.21 1,405.28 1,351.32 Accumulated Depreciation 691.42 563.38 516.18 477.75 424.68 374.28 321.78 287.40 231.51 180.68 Non Current Assets 672.55 813.91 929.00 1,009.05 1,087.71 1,202.46 1,263.78 1,319.18 1,349.72 1,350.77 Capital Work in Progress 10.31 18.84 11.45 19.87 68.60 70.26 78.47 112.83 78.10 161.30 Non Current Investment 29.06 35.53 17.45 31.03 31.02 31.09 17.63 17.52 17.07 17.04 Long Term Loans & Adv. 2.91 6.11 56.95 56.95 63.50 54.24 68.96 72.00 80.78 1.80 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 14.31 0.00 0.00 0.00 0.00 Current Assets 1,074.37 941.88 863.03 836.09 839.26 828.64 921.70 919.82 988.89 1,025.06 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.10 Inventories 428.50 375.67 342.82 316.61 316.91 343.56 356.02 348.31 377.03 451.44 Sundry Debtors 454.78 432.39 396.45 350.85 407.76 357.27 372.45 389.04 443.85 412.71 Cash & Bank 21.48 11.60 10.58 29.97 9.45 16.13 22.58 19.84 20.59 18.28 Other Current Assets 169.61 56.33 38.73 41.82 105.14 111.69 170.66 162.64 147.41 142.52 Short Term Loans & Adv. 113.45 65.90 74.45 96.84 92.09 95.37 157.41 144.03 126.33 115.33 Net Current Assets 739.87 627.36 539.96 480.08 -96.67 -176.37 -29.11 87.01 358.87 362.01 Total Assets 1,746.92 1,755.79 1,792.03 1,845.14 1,926.97 2,031.10 2,185.48 2,239.00 2,338.61 2,375.83

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 99.92 66.32 -46.12 PBT 9.69 16.12 -19.56 -24.01 30.52 -50.85 -68.55 -90.49 -110.49 -105.77 Adjustment 225.59 179.35 176.02 176.17 103.64 167.95 186.52 169.91 144.59 112.39 Changes in Working Capital -99.02 -60.43 -33.30 -226.79 -62.70 -24.43 -37.53 23.91 41.47 -52.74 Cash after chg. in Working capital 136.26 135.03 123.16 -74.63 71.46 92.67 80.44 103.33 75.57 -46.12 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.41 -9.25 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 2.76 -10.17 -10.15 -2.34 -17.25 -30.99 -29.56 -36.64 -27.39 -48.21 Net Fixed Assets -8.59 50.42 31.26 19.05 59.23 21.87 18.07 -34.69 29.24 -176.19 Net Investments -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 0.88 0.06 2.06 Others 66.70 -31.62 -53.93 -21.63 -76.71 -39.89 -47.58 -2.83 -56.69 125.92 Cash from Financing Activity -139.59 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 -63.72 -37.76 65.84 Net Cash Inflow / Outflow -0.57 1.11 -20.25 22.66 -7.78 -7.22 2.95 -0.44 1.17 -28.48 Opening Cash & Equivalents 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75 46.23 Closing Cash & Equivalent 9.38 9.95 8.84 29.09 6.43 14.21 21.43 18.48 18.92 17.75

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 150.27 134.95 125.24 -64.40 73.09 95.57 79.43 98.40 65.53 -46.60 PBT 12.53 18.01 -19.77 -33.26 37.87 -49.96 -67.98 -90.57 -109.35 -104.78 Adjustment 225.66 179.35 176.02 186.26 103.64 167.95 186.30 169.93 144.59 111.52 Changes in Working Capital -87.92 -62.41 -31.01 -214.80 -68.41 -22.42 -38.89 22.87 39.54 -53.34 Cash after chg. in Working capital 150.27 134.95 125.24 -61.80 73.09 95.57 79.43 102.23 74.78 -46.60 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -2.60 0.00 0.00 0.00 -3.83 -9.25 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 4.77 -10.17 -9.10 -12.47 -17.40 -30.94 -29.56 -35.61 -27.39 -48.36 Net Fixed Assets -8.59 50.42 31.26 19.05 59.23 21.87 18.07 -34.69 29.24 -176.19 Net Investments -55.35 -28.97 12.52 0.24 0.23 -12.97 -0.05 0.88 0.06 2.06 Others 68.71 -31.62 -52.88 -31.76 -76.86 -39.84 -47.58 -1.80 -56.69 125.77 Cash from Financing Activity -140.88 -123.75 -133.26 99.62 -61.98 -68.90 -47.92 -63.72 -37.76 66.31 Net Cash Inflow / Outflow 14.17 1.03 -17.12 22.76 -6.30 -4.27 1.94 -0.94 0.38 -28.65 Opening Cash & Equivalents 11.60 10.58 29.97 9.45 16.13 22.58 19.84 20.59 18.28 46.92 Closing Cash & Equivalent 25.77 11.61 10.58 29.97 9.45 16.13 21.78 19.84 20.59 17.82

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 73.68 72.30 70.88 73.53 63.40 56.86 56.11 66.60 92.49 125.37 ROA -0.33% -0.25% -1.15% 2.07% 0.90% -1.89% -2.67% -5.22% -5.23% -5.21% ROE -1.32% -1.04% -5.41% 12.12% 6.51% -16.41% -23.42% -36.57% -28.18% -21.81% ROCE 7.41% 8.24% 6.04% 10.65% 4.45% 2.14% 1.38% -1.52% -1.53% 1.17% Fixed Asset Turnover 0.76 0.65 0.55 0.53 0.53 0.49 0.47 0.47 0.70 0.92 Receivable days 151.57 165.89 173.48 179.63 179.41 184.06 203.30 219.71 156.29 112.06 Inventory Days 140.57 147.38 159.30 158.87 163.74 184.04 195.15 198.67 157.68 156.77 Payable days 107.58 107.82 65.88 60.20 57.51 63.08 84.37 96.76 79.37 74.64 Cash Conversion Cycle 184.56 205.45 266.90 278.30 285.64 305.03 314.08 321.62 234.60 194.19 Total Debt/Equity 2.14 2.28 2.38 3.18 3.76 4.87 6.32 5.17 3.58 2.52 Interest Cover 1.08 1.16 0.82 1.64 1.81 0.38 0.22 -0.22 -0.23 0.14

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 68.33 66.35 70.21 73.01 65.58 58.08 56.78 67.21 93.07 125.78 ROA -0.12% -0.18% -1.17% 1.53% 1.11% -1.86% -2.65% -5.22% -5.18% -5.13% ROE -0.54% -0.78% -5.56% 8.99% 7.89% -15.89% -23.11% -36.36% -27.88% -21.56% ROCE 7.85% 8.31% 5.97% 9.25% 4.59% 2.19% 1.40% -1.52% -1.46% 1.24% Fixed Asset Turnover 0.80 0.67 0.57 0.56 0.56 0.51 0.48 0.48 0.71 0.96 Receivable days 154.46 168.41 174.12 182.19 181.25 185.94 206.44 223.20 158.98 113.33 Inventory Days 140.01 145.99 153.65 152.15 156.48 178.26 190.95 194.38 153.77 149.59 Payable days 109.09 110.78 68.85 63.73 60.79 64.19 12.73 29.95 80.99 75.54 Cash Conversion Cycle 185.38 203.62 258.91 270.60 276.94 300.00 384.67 387.63 231.76 187.37 Total Debt/Equity 2.35 2.56 2.48 3.21 4.38 4.77 6.25 5.12 3.56 2.51 Interest Cover 1.13 1.18 0.81 1.54 2.02 0.39 0.22 -0.22 -0.22 0.15

Top Investors:

edelweiss india special situations fund-ii

ec special situations fund

ashokkumar chandak

edelweiss india special situations fund - eisaf ii onshore fund

sri ganesh biotech private limited

conquer investment & finance pvt. ltd.

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ind-Swift Laboratories gets nod to sell M/s. Halcyon life Sciences
31st Mar 2023, 10:29 AM

The Audit Committee and Board of the Directors of the Company at its meeting held on March 30, 2023 has approved the same
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback